Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines (Bio TCV) in Indonesian Population Compared to PQed TCV

NCT06921460 is registered in ClinicalTrials.gov with PT Bio Farma as lead sponsor.

NCT NCT06921460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06921460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines (Bio TCV) in Indonesian Population Compared to PQed TCV
Lead sponsor
PT Bio Farma
Phase
Observational
Overall status
Not yet recruiting
Start date
June 15, 2025
Completion date
December 31, 2025
Enrollment
624 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibody typhoid vaccine